The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Safety and efficacy of elranatamab as early intervention in patients with high-risk smoldering myeloma: First results from the phase 2 ERASMM (EMN34) study.
 
Cyrille Touzeau
Honoraria - AbbVie; Bristol Myers Squibb; GlaxoSmithKline; Johnson & Johnson; Menarini; Pfizer; Sanofi
Consulting or Advisory Role - AbbVie; Bristol Myers Squibb; GlaxoSmithKline; Johnson & Johnson; Menarini; Pfizer; Sanofi
Research Funding - Sanofi (Inst)
 
Fredrik Schjesvold
Honoraria - Abbvie; Amgen; BMSi; GlaxoSmithKline; Johnson & Johnson/Janssen; Menarini; Oncopeptides; Pfizer; Sanofi; Takeda
Consulting or Advisory Role - BMSi; Caedo therapeutics; Galapagos NV; GlaxoSmithKline; Johnson & Johnson/Janssen; Oncopeptides; Pfizer; Regeneron; Sanofi; Takeda; XNK therapeutics
Research Funding - Circio
Expert Testimony - GlaxoSmithKline
 
Claudio Cerchione
Honoraria - Abbvie; Amgen; BeiGene; Bristol-Myers Squibb/Celgene; GlaxoSmithKline; Janssen; Karyopharm Therapeutics; Menarini; Pfizer; Sanofi/Aventis; SERVIER; Stemline Therapeutics; Takeda
Consulting or Advisory Role - Abbvie; Amgen; BeiGene; Bristol-Myers Squibb/Celgene; GlaxoSmithKline; Janssen; Karyopharm Therapeutics; Menarini; Pfizer; Sanofi; SERVIER; Stemline Therapeutics; Takeda
Speakers' Bureau - Abbvie; Amgen; BeiGene; Bristol-Myers Squibb/Celgene; GlaxoSmithKline; Janssen; Karyopharm Therapeutics; Menarini; Pfizer; Sanofi/Aventis; SERVIER; Stemline Therapeutics; Takeda
 
Xavier Leleu
Honoraria - Abbvie; Amgen; Bristol-Myers Squibb; GlaxoSmithKline; Janssen-Cilag; Kite/Gilead; Novartis; Oncopeptides; Pfizer; Roche; Sanofi; Takeda
Consulting or Advisory Role - Abbvie; Amgen; Bristol-Myers Squibb; Gilead Sciences; GlaxoSmithKline; Janssen-Cilag; Kite/Gilead; Novartis; Pfizer; Roche; Takeda
Travel, Accommodations, Expenses - Takeda
 
Renato Zambello
Consulting or Advisory Role - Amgen; GlaxoSmithKline; Janssen; Menarini; Pfizer; Sanofi
Speakers' Bureau - GlaxoSmithKline; Menarini
 
Carmine Liberatore
Consulting or Advisory Role - Amgen; Menarini Group; Pfizer; Takeda
Speakers' Bureau - Amgen; Johnson & Johnson; Menarini Group; Pfizer; Sanofi; Takeda
 
Inger Nijhof
Honoraria - AbbVie (Inst); Johnson & Johnson (Inst); Kite, a Gilead Company (Inst)
 
Elisa Dama
Patents, Royalties, Other Intellectual Property - IRCCS Fondazione Casa Sollievo della Sofferenza, Italy
 
Thomas Chalopin
Honoraria - Amgen; Bristol-Myers Squibb; GlaxoSmithKline; Grifols; Johnson & Johnson; Pfizer; Sanofi; Stemline Therapeutics; Takeda
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; GlaxoSmithKline; Grifols; Johnson & Johnson; Pfizer; Sanofi; Stemline Therapeutics
 
Pellegrino Musto
Honoraria - AbbVie; Alexion Pharmaceuticals; Amgen; Astellas Pharma; AstraZeneca; BeiGene; Bristol-Myers Squibb; Daiichi Sankyo; Gilead Sciences; GlaxoSmithKline; Grifols; Incyte; Jazz Pharmaceuticals; Johnson & Johnson; Kyowa Kirin; Lilly; Menarini Group; Novartis; Otsuka; Pfizer; Roche; Sanofi; Servier; Sobi; Takeda
Consulting or Advisory Role - AbbVie; Alexion Pharmaceuticals; Amgen; Astellas Pharma; AstraZeneca; BeiGene; Bristol-Myers Squibb; Daiichi Sankyo; Gilead Sciences; GlaxoSmithKline; Grifols; Incyte; Jazz Pharmaceuticals; Johnson & Johnson; Kyowa Kirin; Lilly; Menarini Group; Novartis; Otsuka; Pfizer; Roche; Sanofi; Servier; Sobi; Takeda
Travel, Accommodations, Expenses - AbbVie; Alexion Pharmaceuticals; Amgen; Astellas Pharma; AstraZeneca; BeiGene; Bristol-Myers Squibb; Daiichi Sankyo; Gilead Sciences; GlaxoSmithKline; Grifols; Incyte; Jazz Pharmaceuticals; Johnson & Johnson; Kyowa Kirin; Lilly; Menarini Group; Novartis; Otsuka; Pfizer; Roche; Sanofi; Servier; Sobi; Takeda
 
Alessandro Rambaldi
Consulting or Advisory Role - Abbvie; Amgen; Incyte; ITALFARMACO; Jazz Pharmaceuticals; Kite/Gilead; Novartis; Omeros; Otsuka; Sanofi
 
Andrea Crespo
No Relationships to Disclose
 
Silvia Mangiacavalli
Honoraria - Bristol-Myers Squibb; GlaxoSmithKline; Janssen; Menarini Group; Oncopeptides; Pfizer
Consulting or Advisory Role - GlaxoSmithKline; Janssen; Menarini Group; Oncopeptides; Pfizer
Speakers' Bureau - Amgen; Bristol-Myers Squibb; GlaxoSmithKline; Janssen; Menarini Group; Oncopeptides; Pfizer
Travel, Accommodations, Expenses - Bristol-Myers Squibb; GlaxoSmithKline; Janssen; Menarini Group; Oncopeptides; Pfizer
 
Komivi Agbetsivi
No Relationships to Disclose
 
Laure Vincent
Honoraria - Edimark
Consulting or Advisory Role - Janssen
Travel, Accommodations, Expenses - Janssen; Pfizer
 
Mario Boccadoro
Honoraria - Abbvie; Amgen; Bristol-Myers Squibb; Celgene; Janssen; Novartis; Sanofi
Consulting or Advisory Role - GlaxoSmithKline; Janssen
Research Funding - Amgen (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Janssen (Inst); Mundipharma (Inst); Novartis (Inst); Sanofi (Inst)
 
Pieter Sonneveld
Leadership - European Myeloma Network
Consulting or Advisory Role - Amgen; CARsgen Therapeutics; Celgene; Janssen; Karyopharm Therapeutics
Research Funding - Amgen (Inst); BMS (Inst); Janssen (Inst); Skyline Diagnostics (Inst)
 
Annemiek Broijl
Honoraria - Amgen; Bristol-Myers Squibb; Janssen; Sanofi
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Janssen; Sanofi